IDEAYA Biosciences, Inc. (IDYA) Form 8-K Material Events
IDEAYA Biosciences, Inc. (IDYA) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: IDYA
CIK: 1676725
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
PricewaterhouseCoopers LLP
Auditor SinceSince 12/31/2018 12:00:00 AM
Lead Engagement PartnerMichael Jerome
Audit LocationSan Jose, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-08 | 2026-10-06 | FORM 4 | 0001610717-26-000434 | View SEC Doc Filr Page |
| 144 | 2026-10-06 | — | 144 Filing | 0001968582-26-001043 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-14 | — | SCHEDULE 13G Filing | 0001104659-26-097056 | View SEC Doc Filr Page |
| 10-Q | 2026-08-04 | 2026-06-30 | 10-Q | 0001193125-26-332774 | View SEC Doc Filr Page |
| 8-K | 2026-08-04 | 2026-08-04 | 8-K | 0001193125-26-331381 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-07-31 | — | SCHEDULE 13G Filing | 0002100119-26-001376 | View SEC Doc Filr Page |
| 4 | 2026-07-09 | 2026-07-07 | FORM 4 | 0001610717-26-000336 | View SEC Doc Filr Page |
| 144 | 2026-07-07 | — | 144 Filing | 0001968582-26-000707 | View SEC Doc Filr Page |
| 8-K | 2026-06-23 | 2026-06-16 | 8-K | 0001193125-26-279427 | View SEC Doc Filr Page |
| 4 | 2026-06-18 | 2026-06-16 | 4 Filing | 0001610717-26-000265 | View SEC Doc Filr Page |
| 4 | 2026-06-18 | 2026-06-16 | 4 Filing | 0001610717-26-000264 | View SEC Doc Filr Page |
| 4 | 2026-06-18 | 2026-06-16 | 4 Filing | 0001610717-26-000263 | View SEC Doc Filr Page |
| 4 | 2026-06-18 | 2026-06-16 | 4 Filing | 0001610717-26-000261 | View SEC Doc Filr Page |
| 4 | 2026-06-18 | 2026-06-16 | 4 Filing | 0001610717-26-000260 | View SEC Doc Filr Page |
| 4 | 2026-06-18 | 2026-06-16 | 4 Filing | 0001610717-26-000259 | View SEC Doc Filr Page |
| 8-K | 2026-06-10 | 2026-06-08 | 8-K | 0001193125-26-265833 | View SEC Doc Filr Page |
| 424B5 | 2026-06-09 | — | 424B5 | 0001193125-26-264032 | View SEC Doc Filr Page |
| 424B5 | 2026-06-08 | — | 424B5 | 0001193125-26-261756 | View SEC Doc Filr Page |
| 3 | 2026-06-05 | 2026-03-18 | 3 Filing | 0001610717-26-000184 | View SEC Doc Filr Page |
| 8-K | 2026-06-03 | 2026-06-03 | 8-K | 0001193125-26-254476 | View SEC Doc Filr Page |
| 8-K | 2026-06-01 | 2026-06-01 | 8-K | 0001193125-26-251399 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-15 | — | SCHEDULE 13G/A Filing | 0001274173-26-000141 | View SEC Doc Filr Page |
| 8-K | 2026-05-05 | 2026-05-05 | 8-K | 0001193125-26-206806 | View SEC Doc Filr Page |
| 424B5 | 2026-05-05 | — | 424B5 | 0001193125-26-206788 | View SEC Doc Filr Page |
| S-3ASR | 2026-05-05 | — | S-3ASR | 0001193125-26-206523 | View SEC Doc Filr Page |